Activity of JC virus archetype and PML-type regulatory regions in glial cells

Journal of General Virology

Volumn 78, Issue 1, 1997, Pages 163-169

  Ault, Grace S ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; DNA; VIRUS CAPSID ANTIGEN; VIRUS T ANTIGEN;

ARTICLE; CONTROLLED STUDY; DNA REPLICATION; GLIA CELL; HUMAN; HUMAN CELL; JC VIRUS; NONHUMAN; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROMOTER REGION; REGULATOR GENE; REPORTER GENE; TRANSCRIPTION REGULATION; VIRUS GENE;

JC VIRUS; MIRIDAE;

EID: 0031023677     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-1-163     Document Type: Article

References (50)

1. Ahmed, S., Rappaport, J., Tada, H., Kerr, D. & Khalili, K. (1990). A nuclear protein derived from brain cells stimulates transcription of the human neurotropic virus promoter, JCVE, in vitro. Journal of Biological Chemistry 265, 33899-13905.
2. Amemiya, K., Traub, R., Durham, L. & Major, E. O. (1989). Interaction of a nuclear factor-1-like protein with the regulatory region of the human polyomavirus JC virus. Journal of Biological Chemistry 264, 7025-7032.
3. Arthur, R. R. & Shah, K. V. (1989). Occurrence and significance of papovaviruses BK and JC in the urine. Progress in Medical Virology 36, 42-61.
4. Atwood, W. J., Amemiya, K., Traub, R., Harms, J. & Major, E. O. (1992). Interaction of the human polyomavirus, JCV, with human B-lymphocytes. Virology 190, 716-723.
5. Atwood, W. J., Wang, L., Durham, L. C., Amemiya, K., Traub, R. G. & Major, E. O. (1995). Evaluation of the role of cytokine activation in the multiplication of JC virus (JCV) in human fetal glial cells. Journal of Neurovirology 1, 40-49.
6. Ault, G. S. & Stoner, G. L. (1992). Two major types of JC virus defined in progressive multifocal leukoencephalopathy brain by early and late coding region DNA sequences. Journal of General Virology 73, 2669-2678.
7. Ault, G. S. & Stoner, G. L. (1993). Human polyomavirus JC promoter/ enhancer rearrangement patterns from progressive multifocal leukoencephalopathy brain are unique derivatives of a single archetypal structure. Journal of General Virology 74, 1499-1507.
8. Ault, G. S. & Stoner, G. L. (1994). Brain and kidney of progressive multifocal leukoencephalopathy patients contain identical rearrangements of the JC virus promoter/enhancer. Journal of Medical Virology 44, 298-304.
9. Cassill, J. A. & Subramani, S. (1989). A naturally occurring deletion in the enhancer repeats of the human papovavirus BK optimizes early enhancer function at the expense of late promoter activity. Virology 170, 296-298.
10. Chowdhury, M., Kundu, M. & Khalili, K. (1993). GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCVL, in cells derived from central nervous system. Oncogens 8, 887-892.
11. Coleman, D. V., Wolfendale, M. R., Daniel, R. A., Dhanjal, N. K., Gardner, S. D., Gibson, P. E. & Field, A. M. (1980). A prospective study of human polyomavirus infection in pregnancy. Journal of Infectious Diseases 142, 1-8.
12. Daniel, A. M., Swenson, J. J., Mayreddy, R. P. R., Khalili, K. & Frisque, R. J. (1996). Sequences within the early and late promoters of archetype JC virus restrict viral DNA replication and infectivity. Virology 216, 90-101.
13. Daniel, A. M. & Frisque, R. J. (1993). Transcription initiation sites of prototype and variant JC virus early and late messenger RNAs. Virology 194, 97-109.
14. Feigenbaum, L., Khalili, K., Major, E. O. & Khoury, G. (1987). Regulation of the host range of human papovavirus JCV. Proceedings of the National Academy of Sciences, USA 84, 3695-3698.
15. Flaegstad, T., Sundsfjord, A., Arthur, R. R., Pedersen, M., Traavik, T. & Subramani, S. (1991). Amplification and sequencing of the control regions of BK and JC virus from human urine by polymerase chain reaction. Virology 180, 553-560.
16. Frisque, R. J., Bream, G. L. & Cannella, M. T. (1984). Human polyomavirus JC virus genome. Journal of Virology 51, 458-469.
17. Frisque, R. J. & White, F. A., III (1992). The molecular biology of JC virus, causative agent of progressive multifocal leukoencephalopathy. In Neurovirology - Pathogenesis of Viral CNS Infections, pp. 25-158. Edited by R. P. Roos & N. J. Totowa. New York: Humana.
18. Heilbronn, R., Albrecht, I., Stephan, S., Burkle, A. & zur Hausen, H. (1993). Human cytomegalovirus induces JC virus DNA replication in human fibroblasts. Proceedings of the National Academy of Sciences, USA 90, 11406-11410.
19. Henson, J., Saffer, J. & Furneaux, H. (1992). The transcription factor Sp1 binds to the JC virus promoter and is selectively expressed in glial cells in human brain. Annals of Neurology 32, 72-77.
20. Hirt, B. (1967). Selective extraction of polyoma DNA from infected mouse cell cultures. Journal of Molecular Biology 26, 365-369.
21. Hogan, T. F., Padgett, B. L. & Walker, D. L. (1991). Human polyomaviruses. In Textbook of Human Virology, pp. 970-1000. Edited by R. B. Belshe. St Louis: Mosby.
22. Houff, S. A., Major, E. O., Katz, D. A., Kufta, C. V., Sever, J. L., Pittaluga, S., Roberts, J. R., Gitt, J., Saini, N. & Lux, W. (1988). Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. New England Journal of Medicine 318, 301-305.
23. Iida, T., Kitamura, T., Guo, J., Taguchi, F., Aso, Y., Nagashima, K. & Yogo, Y. (1993). Origin of JC polyomavirus variants associated with progressive multifocal leukoencephalopathy. Proceedings of the National Academy of Sciences, USA 90, 5062-5065.
24. Kenney, S., Natarajan, V., Strike, D., Khoury, G. & Salzman, N. P. (1984). JC virus enhancer-promoter active in human brain cells. Science 226, 1337-1339.
25. Kenney, S., Natarajan, V. & Salzman, N. P. (1986). Mapping 5′ termini of JC virus late RNA. Journal of Virology 58, 216-219.
26. Kitamura, T., Aso, Y., Kuniyoshi, N., Hara, K. & Yogo, Y. (1990). High incidence of urinary JC virus excretion in nonimmunosuppressed older patients. Journal of Infectious Diseases 161, 1128-1133.
27. Kitamura, T., Yogo, Y., Kunitake, T., Suzuki, K., Tajima, A. & Kawabe, K. (1994). Effect of immunosuppression on the urinary excretion of BK and JC polyomaviruses in renal allograft recipients. International Journal of Urology 1, 28-32.
28. Krebs, C. J., McAvoy, M. T. & Kumar, G. (1995). The JC virus minimal core promoter is glial cell specific in vivo. Journal of Virology 69, 2434-2442.
29. Lashgari, M. S., Tada, H., Amini, S. & Khalili, K. (1989). Regulation of JCVL promoter function: transactivation of JCVL promoter by JCV and SV40 early proteins. Virology 170, 292-295.
30. Loeber, G. & Dörries, K. (1988). DNA rearrangements in organ-specific variants of polyomavirus JC strain GS. Journal of Virology 62, 1730-1735.
31. Lynch, K. J. & Frisque, R. J. (1990). Identification of critical elements within the JC virus DNA replication origin. Journal of Virology 64, 5812-5822.
32. Major, E. O. & Ault, G. S. (1995). Progressive multifocal leukoencephalopathy: clinical and laboratory observations on a viral induced demyelinating disease in the immunodeficient patient. Current Opinion in Neurology 8, 184-190.
33. Markowitz, R. B., Eaton, B. A., Kubik, M. F., Latorra, D., McGregor, J. A. & Dynan, W. S. (1991). BK virus and JC virus shed during pregnancy have predominantly archetypal regulatory regions. Journal of Virology 65, 4515-4519.
34. Markowrtz, R. B., Thompson, H. C., Mueller, J. F., Cohen, J. A. & Dynan, W. S. (1993). Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects. Journal of Infectious Diseases 167, 13-20.
35. Nakshatri, H., Pater, A. & Pater, M. M. (1990). Activity and enhancer binding factors for JC virus regulatory elements in differentiating embryonal carcinoma cells. Virology 177, 784-789.
36. Padgett, B. L. & Walker, D. L. (1973). Prevalence of antibodies in human sera against JC virus, an isolate of progressive multifocal leukoencephalopathy. Journal of Infectious Diseases 127, 467-470.
37. Raj, G. V. & Khalili, K. (1995). Transcriptional regulation: lessons from the human neurotropic polyomavirus, JCV. Virology 213, 283-291.
38. Renner, K., Leger, H. & Wegner, M. (1994). The POU domain protein Tst-1 and papovaviral large tumor antigen function synergistically to stimulate glia-specific gene expression of JC virus. Proceedings of the National Academy of Sciences, USA 91, 6433-6437.
39. Sock, E., Wegner, M. & Grummt, F. (1991). DNA replication of human polyomavirus JC is stimulated by NF-I in vivo. Virology 182, 298-308.
40. Sock, E., Wegner, M., Fortunato, E. A. & Grummt, F. (1993). Large T-antigen and sequences within the regulatory region of JC virus both contribute to the features of JC virus DNA replication. Virology 197, 537-548.
41. Sock, E., Renner, K., Feist, D., Leger, H. & Wegner, M. (1996). Functional comparison of PML-type and archetype strains of JC virus. Journal of Virology 70, 1512-1520.
42. Tada, H., Lashgari, M. S., Rappaport, J. & Khalili, K. (1989). Cell type-specific expression of JC virus early promoter is determined by positive and negative regulation. Journal of Virology 63, 463-466.
43. Tada, H., Rappaport, J., Lashgari, M. S., Amini, S., Wong-Staal, F. & Khalili, K. (1990). Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proceedings of the National Academy of Sciences, USA 87, 3479-3483.
44. Tamura, T., Inoue, T., Nagata, K. & Mikoshiba, K. (1988). Enhancer of human polyoma JC virus contains nuclear factor i-binding sequences; analysis using mouse brain nuclear extracts. Biochemical and Biophysical Research Communications 157, 419-425.
45. Tominaga, T., Yogo, Y., Kitamura, T. & Aso, Y. (1992). Persistence of archetypal JC virus DNA in normal renal tissue derived from tumor-bearing patients. Virology 186, 736-741.
46. Tornatore, C., Berger, J. R., Houff, S. A., Curfman, B., Meyers, K., Winfield, D. & Major, E. O. (1992). Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy. Annals of Neurology 31, 454-462.
47. Tornatore, C., Amemiya, K., Atwood, W. J., Conant, K. & Major, E. O. (1994). JC virus: current concepts and controversies in the molecular virology and pathogenesis of progressive multifocal leukoencephalopathy. Reviews in Medical Virology 4, 197-219.
48. Wegner, M., Drolet, D. W. & Rosenfeld, M. G. (1993). Regulation of JC virus by the POU-domain transcription factor Tst-1: implications for progressive multifocal leukoencephalopathy. Proceedings of the National Academy of Sciences, USA 90, 4743-4747.
49. Yogo, Y., Kitamura, T., Sugimoto, C., Ueki, T., Aso, Y., Hara, K. & Taguchi, F. (1990). Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals. Journal of Virology 64, 3139-3143.
50. Yogo, Y., Guo, J., Iida, T., Satoh, K.-I., Taguchi, F., Takahashi, H., Hall, W. W. & Nagashima, K. (1994). Occurrence of multiple JC virus variants with distinctive regulatory sequences in the brain of a single patient with progressive multifocal leukoencephalopathy. Virus Genes 8, 99-105.